These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17208672)

  • 21. Cost considerations of the new fixed combinations for glaucoma medical therapy.
    Ventura MP; Saheb NE; Solari HP; Saraiva VS; Vianna RN; Burnier MN
    J Clin Pharm Ther; 2005 Jun; 30(3):251-4. PubMed ID: 15896242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
    Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
    Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.
    Alasbali T; Smith M; Geffen N; Trope GE; Flanagan JG; Jin Y; Buys YM
    Am J Ophthalmol; 2009 Jan; 147(1):33-38.e2. PubMed ID: 18760766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
    van der Valk R; Webers CA; Hendrikse F; de Vogel SC; Prins MH; Schouten JS
    Acta Ophthalmol; 2008 Jun; 86(4):415-8. PubMed ID: 18028236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
    Mansouri K; Orguel S; Mermoud A; Haefliger I; Flammer J; Ravinet E; Shaarawy T
    Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of ocular hypotensive eyedrops on intraocular pressure fluctuation with postural change in eyes with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Am J Ophthalmol; 2007 Apr; 143(4):693-5. PubMed ID: 17386282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST; Bernstein P; Hollander DA
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic study of factors affecting eye drop size and dosing variability.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2005 Dec; 60(12):917-21. PubMed ID: 16398268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?
    German EJ; Hurst MA; Wood D
    Eye (Lond); 1999; 13 ( Pt 1)():93-100. PubMed ID: 10396391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
    Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stabilization mechanism of latanoprost.
    Ochiai A; Danjo K
    Int J Pharm; 2011 May; 410(1-2):23-30. PubMed ID: 21397673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size.
    Platt R; Reardon G; Mozaffari E
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S17-23. PubMed ID: 14697911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
    Aptel F; Cucherat M; Denis P
    J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.